Tags

Type your tag names separated by a space and hit enter

Migraine prevention.
Pract Neurol. 2007 Nov; 7(6):383-93.PN

Abstract

Preventive medications reduce migraine frequency and severity, and improve migraine-specific quality of life. Recent evidence also suggests that these same medications enhance the patient's response to acute migraine therapies, and may also reduce the likelihood of developing chronic daily headache. However, many patients who should receive or be offered preventive treatment are not. Most patients can be successfully managed when patient and physician expectations are realistic and aligned, the selection of preventive medications is individualised, and the initiation and titration strategy is appropriate and carefully followed. Rational combinations of preventive medications may also be useful. This review provides an evidence and experience-based approach to the preventive treatment of migraine.

Authors+Show Affiliations

Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA. Dodick.David@mayo.eduNo affiliation info available

Pub Type(s)

Case Reports
Journal Article
Review

Language

eng

PubMed ID

18024778

Citation

Dodick, D W., and S D. Silberstein. "Migraine Prevention." Practical Neurology, vol. 7, no. 6, 2007, pp. 383-93.
Dodick DW, Silberstein SD. Migraine prevention. Pract Neurol. 2007;7(6):383-93.
Dodick, D. W., & Silberstein, S. D. (2007). Migraine prevention. Practical Neurology, 7(6), 383-93.
Dodick DW, Silberstein SD. Migraine Prevention. Pract Neurol. 2007;7(6):383-93. PubMed PMID: 18024778.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Migraine prevention. AU - Dodick,D W, AU - Silberstein,S D, PY - 2007/11/21/pubmed PY - 2008/1/9/medline PY - 2007/11/21/entrez SP - 383 EP - 93 JF - Practical neurology JO - Pract Neurol VL - 7 IS - 6 N2 - Preventive medications reduce migraine frequency and severity, and improve migraine-specific quality of life. Recent evidence also suggests that these same medications enhance the patient's response to acute migraine therapies, and may also reduce the likelihood of developing chronic daily headache. However, many patients who should receive or be offered preventive treatment are not. Most patients can be successfully managed when patient and physician expectations are realistic and aligned, the selection of preventive medications is individualised, and the initiation and titration strategy is appropriate and carefully followed. Rational combinations of preventive medications may also be useful. This review provides an evidence and experience-based approach to the preventive treatment of migraine. SN - 1474-7766 UR - https://www.unboundmedicine.com/medline/citation/18024778/Migraine_prevention_ L2 - http://pn.bmj.com/cgi/pmidlookup?view=long&pmid=18024778 DB - PRIME DP - Unbound Medicine ER -